scispace - formally typeset
M

Mila Kovacheva-Slavova

Researcher at Sofia Medical University

Publications -  22
Citations -  93

Mila Kovacheva-Slavova is an academic researcher from Sofia Medical University. The author has contributed to research in topics: Medicine & Pancreatitis. The author has an hindex of 3, co-authored 17 publications receiving 51 citations.

Papers
More filters
Journal ArticleDOI

Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations

Andrea Párniczky, +100 more
- 19 Apr 2019 - 
TL;DR: The authors formulated four consensus statements to urge reduction of unjustified antibiotic treatment in acute pancreatitis and to use procalcitonin rather than WBC or CRP as biomarkers to guide decision-making.
Journal ArticleDOI

Acid suppression therapy, gastrointestinal bleeding and infection in acute pancreatitis - An international cohort study.

Alexandra Demcsák, +98 more
- 22 Aug 2020 - 
TL;DR: Although ASD therapy is widely used, it is unlikely to have beneficial effects either on the outcome of AP or on the prevention of GI bleeding during AP, and it should be substantially decreased in the therapeutic management of AP.
Book ChapterDOI

Current View on Autoimmune Gastritis

TL;DR: Autoimmune gastritis (AIG) is a chronic inflammatory disease of the gastric corpus and fundus that might manifest with multifactorial iron deficiency anemia, vitamin B12 deficiency (pernicious anemia), neurological and neuropsychiatric conditions, small intestinal bacterial overgrowth and gastrointestinal infections.
Book ChapterDOI

Helicobacter pylori Infection

TL;DR: The standard triple therapy is largely replaced with a quadruple therapy, especially in countries with high resistance rates, and Antimicrobial susceptibility testing should be performed after the second-line treatment failure, leading to an individualized patient treatment.
Journal ArticleDOI

Pancreatic enzyme replacement therapy in patients with pancreatic exocrine insufficiency

TL;DR: Proper follow-up and correction of suboptimal PERT reduce the risk of severe malnutrition complications, associated morbidity and mortality and ensures better quality of life for patients with PEI.